Clearbridge Health

CLEARBRIDGE Health has recorded a “material decrease” in its FY2023 financial performance amid lower revenues from several business segments, the Catalist-listed company announced on Friday (Feb 9).

CLEARBRIDGE Health is considering Biolidics’ proposal to repay its debt, which amounts to some S$2.1 million, by the extended deadline of Dec 23, 2023.

A CIVIL lawsuit in Indonesia against Clearbridge Health chief executive Jeremy Yee and the company’s former subsidiary Indo Genesis Medika (IGM) has been withdrawn.

MEDICAL tech company Clearbridge Health’s executive director and chief executive Jeremy Yee is among the defendants named in a civil suit filed by the shareholder of a former subsidiary, the company s...

PRECISION medicine firm Clearbridge Health is looking to enter the business of investing in and divesting healthcare companies.

CLEARBRIDGE Health on Wednesday said its second batch of Sinopharm Covid-19 vaccines have arrived in Singapore.

SHARES of Clearbridge Health are up in early trade on Tuesday, after it said on Monday that its subsidiary has entered into a contract to purchase the Sinopharm Covid-19 vaccine directly from its manu...

CATALIST-LISTED Clearbridge Health said on Monday that its subsidiary has entered into a contract to purchase the Sinopharm Covid-19 vaccine directly from its manufacturer.

A LAWSUIT filed by a joint venture partner of a ClearBridge Health unit has been dismissed by an Indonesian court due to a jurisdiction issue, the Catalist-listed company announced in a Tuesday bourse...